Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma

NCT04925193 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma in Relapse

Interventions

DRUG: Selinexor
DRUG: Pomalidomide
DRUG: Daratumumab
DRUG: Carfilzomib
DRUG: Dexamethasone

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]